Abstract Whole mount preparations of mouse mammary glands are useful for evaluating overall changes in growth and morphology, and are essential for detecting and evaluating focal or regionally-localized phenotypes that would be difficult to detect or analyze using other techniques. We present three newly developed methods for preparing whole mounts of mammary glands from genetically-engineered mice expressing fluorescent proteins, as well as using either neutral red or a variety of fluorescent dyes. Unlike traditional hematoxylin-or carmine-stained preparations, neutral red-stained and some fluorescent preparations can be used for several common downstream analyses.
Introduction
Whole mount preparations of mouse mammary gland have been used for decades as tools for the detecting and evaluating of changes in ductal/alveolar growth, patterning, and morphogenesis (reviewed previously in [1] ). Whole mount preparations are particularly useful in the screening and first-line analysis of genetically modified animals since developmental defects may not be detected or analyzed easily at the histological level. Further, if a given defect is manifest in only a small region of a given mammary gland, or in a small fraction of mammary glands from a number of animals, whole mount preparations are essential for detecting and analyzing these changes Traditionally, whole mount preparations are stained with either iron hematoxylin, carmine-alum, or less frequently trypan blue. In the case of iron hematoxylin and carminealum, staining conditions generally preclude the subsequent use of these preparations for downstream analyses such as immunolocalization or in situ hybridization on histological sections. The methods described herein were developed as part of an effort to identify staining conditions that would allow some, or all, of these downstream applications to be pursued. While an exhaustive evaluation of the utility of these preparations in downstream applications has not yet been conducted, in the case of neutral red-stained preparations and preparations from fluorescent-tagged glands, whole mount material can be used for subsequent immunolocalization studies using a number of antibodies.
Materials and Methods

General Considerations
Removal of Mammary Glands and Preparation For a detailed description of the techniques for removing mam-mary glands, please refer to Rasmussen et al. [1] . For optimal results, remove the muscle separating the #2 and #3 thoracic mammary glands as it can interfere with visualization of the ductal tree.
Methods for spreading mammary glands on a solid substrate for staining vary greatly from lab to lab. In our laboratory, we use plastic petri dishes, 6-well plates, or standard histological cassettes routinely. For optimal results, spread the mammary gland as flat as possible.
Fixation For standard whole mounts, neutral red staining, and fluorescent dye staining, we routinely fix mammary glands using ice-cold 4% (w/v) paraformaldehyde (PFA) at 4°C for 1-3 h, depending on the downstream analyses required. Other fixation techniques have not been tested, but should provide comparable results based on their utility in standard staining protocols [1] .
Fluorescent proteins perform well using PFA fixation, although signal intensity can be attenuated. If fluorescence signal is weak, glands can be imaged prior to fixation (see Method 1, "Protocol B"). The effect of other fixation techniques on fluorescent protein signal intensity in the mammary gland has not yet been investigated. , and a number of red fluorescent protein (RFP) variants. We have used the following technique to prepare whole mount preparations using ECFP (Fig. 1a,b) , EGFP ( Fig. 1c,d ), and a tdTomato Red (Fig. 1e,f) as the fluorescent tags. In addition to fluorescence stereomicroscopy, glands can be imaged as whole mounts using confocal microscopy ( Fig. 1g,h ) [2] [3] [4] [5] [6] [7] [8] .
Treatment of glands expressing fluorescent proteins with several commonly used reagents quenches fluorescence considerably. These reagents include: methanol, ethanol, acetone, and xylenes. There are a number of fluorescent dyes that may be useful for staining whole mount preparations of mammary glands [2] . We have evaluated three commonly available nucleic acid-intercalating dyes, ethidium bromide (Fig. 2a,b) , propidium iodide (Fig. 2c,d) , and 4′,6-diamidino-2-phenylindole (DAPI) (Fig. 2e,f) . In principle, this method should work for any other nucleic acid-binding dye. While DNAintercalating dyes are useful, special care should be taken since these dyes are known to be mutagenic and/or carcinogenic, in many cases.
A variation of this method may also be useful with protein-binding dyes (e.g. carboxyfluorescein succinimidyl ester (CFSE)). However, lipid-binding dyes (e.g. PKH26) will likely require an entirely different method since lipid is removed from the mammary gland using this procedure by treatment with acetone and glycerol. Figure 1 Whole mounts of mouse mammary glands expressing fluorescent proteins. a Mature thoracic (#3) mammary gland harvested from a mouse expressing the ECFP gene driven by the cytomegalovirus (CMV) immediate early enhancer coupled to the chicken beta actin promoter. Bar represents 1 mm. b ECFP gland shown at higher magnification. c Thoracic (#3) mammary gland harvested from a mature mouse expressing the EGFP gene driven by the CMV immediate early enhancer coupled to the chicken beta actin promoter. d EGFP-expressing gland shown at higher magnification. e Thoracic (#3) mammary gland harvested from a mature mouse expressing a membrane-targeted tdTomato driven by the chicken beta actin promoter. f tdTomato-expressing mammary gland shown at higher magnification. g Whole mount of an ECFP expressing mammary gland imaged using confocal microscopy. h Mammary duct from a mouse expressing a fibroblast specific protein-1 (Fsp-1) Cre recombinase and a Cre reporter which expresses the tdTomato protein in nonrecombined cells and EGFP in recombined cells that was imaged using confocal microscopy. Fibroblasts within the stroma appear green indicating active expression of Cre recombinase while the ductal epithelium remains red indicating a lack of Cre expression. Neutral red is a useful alternative to hematoxylin or carmine-alum for staining mouse mammary glands as whole mounts in that it not only allows visualization of mammary structures [9, 10] (Fig. 3a,b) , but also allows evaluation of identified structures using immunolocalization (Fig. 3c,d ). Use of neutral red-stained preparations in subsequent in situ hybridization should also be possible, but this has not yet been tested. The neutral red staining method is somewhat limited by the fact that contrast between epithelial structures and surrounding adipose stroma is not as good as with traditional methods. Note: if glands are stored in methyl salicylate, methyl salicylate must be removed prior to embedding in paraffin by washing with three changes of xylenes, 1 h each. The effect of methyl salicylate on subsequent immunostaining has not been tested using this protocol.
